C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) A61K 31/70 (2006.01) C12N 15/11 (2006.01)
Patent
CA 2181546
Disclosed are oligonucleotides which hybridize to a portion of respiratory syncytial virus (RSV) genomic RNA under physiological conditions, and, in doing so, inhibit viral replication. Also disclosed are pharmaceutical compositions and methods useful for inhibiting and treating RSV infection and including at least one or two of these oligonucleotides, or at least one of these oligonucleotides and ribavirin.
L'invention se rapporte à des oligonucléotides qui s'hybrident sur une partie de l'ARN génomique du virus respiratoire syncitial (VRS) selon des états physiologiques, et se faisant, inhibent la réplication virale. L'invention se rapporte également à des compositions pharmaceutiques et à des procédés utilisés pour inhiber et traiter les infections dues au VRS, ces compositions renfermant au moins un ou deux de ces oligonucléotides ou au moins un de ces oligonucléotides et la ribavirine.
Brown-Vargas Patrick E.
Kilkuskie Robert E.
Hybridon Inc.
Mbm & Co.
LandOfFree
Oligonucleotides with anti-respiratory syncytial virus activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides with anti-respiratory syncytial virus activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides with anti-respiratory syncytial virus activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1753207